Clearside Biomedical, Inc.
14 clinical trials · Sponsor
◉ Watch Clearside Biomedical, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration (NCT05891548) | Clearside Biomedical, Inc. | 2023-05-31 |
| Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study (NCT05131646) | Clearside Biomedical, Inc. | 2021-10-08 |
| Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD (NCT04626128) | Clearside Biomedical, Inc. | 2020-12-15 |
| Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO (NCT03203447) | Clearside Biomedical, Inc. | 2018-03-05 |
| MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 (NCT02952001) | Clearside Biomedical, Inc. | 2017-12-13 |
Track Clearside Biomedical, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.